Shawn Comella

Chief Executive Officer & Founder @Triclinic Labs, Llc

Lafayette, IN, US

Triclinic Labs provides state-of-the-art solid-state contract pharmaceutical and fine chemical development services. We are world leaders in materials characterization, solid form screening and selection, crystalline and non crystalline development, and GMP method validation and release testing. Leverage our innovation and experience to improve both your molecules and intellectual property portfolio.The scientists at Triclinic Labs have more than two decades of proven pharmaceutical development and intellectual property (IP) support experience. We\'ve collaborated on more than 1500 polymorph, salt, cocrystal, and amorphous material development projects. Our clients include 98% of the top 100 global pharmaceutical companies and hundreds of smaller innovators and future success stories. Our scientists have served as experts in more than 150 IP matters world-wide. We can help you with even the most challenging solid-state chemistry development and control issues and associated patent prosecution and litigation. With our expert physical and analytical chemistry capabilities and extensive instrumentation, we’ll collaborate to maximize your compound\'s clinical and market potential…Look to us as your source for expert solid form development, testing, and

American Cancer Society

Cancer Research Fellowship